Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance

被引:11
作者
El-Helou, Nancy [1 ]
Al-Hajje, Amal [1 ]
Ajrouche, Rola [1 ]
Awada, Sanaa [1 ]
Rachidi, Samar [1 ]
Zein, Salam [1 ]
Salameh, Pascale [1 ]
机构
[1] Lebanese Univ, Fac Pharm, Clin & Epidemiol Res Lab, Beirut, Lebanon
关键词
adverse drug events; vitamin K antagonists; bleeding risks; therapeutic imbalance;
D O I
10.2147/VHRM.S41144
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Adverse drug events (ADE) occur frequently during treatment with vitamin K antagonists (AVK) and contribute to increase hemorrhagic risks. Methods: A retrospective study was conducted over a period of 2 years. Patients treated with AVK and admitted to the emergency room of a tertiary care hospital in Beirut were included. The aim of the study was to identify ADE characterized by a high international normalized ratio (INR) and to determine the predictive factors responsible for these events. Statistical analysis was performed with the SPSS statistical package. Results: We included 148 patients. Sixty-seven patients (47.3%) with an INR above the therapeutic range were identified as cases. The control group consisted of 81 patients (54.7%) with an INR within the therapeutic range. Hemorrhagic complications were observed in 53.7% of cases versus 6.2% of controls (P < 0.0001). No significant difference was noticed between cases and controls regarding the indication and the dose of AVK. Patients aged over 75 years were more likely to present an INR above the therapeutic range (58.2%, P = 0.049). Recent infection was present in 40.3% of cases versus 6.2% of controls (P < 0.0001) and hypoalbuminemia in 37.3% of cases versus 6.1% of controls (P < 0.0001). Treatment with antibiotics, amiodarone, and anti-inflammatory drugs were also factors of imbalance (P < 0.0001). Conclusion: Many factors may be associated with ADE related to AVK. Monitoring of INR and its stabilization in the therapeutic range are important for preventing these events.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 50 条
[41]   The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy [J].
Smith, Michael A. ;
Love, Bryan L. ;
Mohammad, Rima A. .
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (11) :1649-1652
[42]   Prevalence of Topical Corticosteroids Related Adverse Drug Events and Associated Factors in Selected Community Pharmacies and Cosmetic Shops of Addis Ababa, Ethiopia [J].
Tsegaye, Mahlet ;
Shimels, Tariku ;
Bilal, Arebu, I .
SUDAN JOURNAL OF MEDICAL SCIENCES, 2018, 13 (01) :62-77
[43]   Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods [J].
Fanikos, John ;
Tawfik, Yahya ;
Almheiri, Danya ;
Sylvester, Katelyn ;
Buckley, Leo F. ;
Dew, Chris ;
Dell'Orfano, Heather ;
Armero, Andre ;
Bejjani, Antoine ;
Bikdeli, Behnood ;
Campia, Umberto ;
Davies, Julia ;
Fiumara, Karen ;
Hogan, Heather ;
Khairani, Candrika Dini ;
Krishnathasan, Darsiya ;
Lou, Junyang ;
Makawi, Alaa ;
Morrison, Ruth H. ;
Porio, Nicole ;
Tristani, Anthony ;
Connors, Jean M. ;
Goldhaber, Samuel Z. ;
Piazza, Gregory .
AMERICAN JOURNAL OF MEDICINE, 2023, 136 (09) :927-+
[44]   Sex differences in text-mined possible adverse drug events associated with drugs for psychosis [J].
Sorup, Freja Karuna Hemmingsen ;
Eriksson, Robert ;
Westergaard, David ;
Hallas, Jesper ;
Brunak, Soren ;
Ejdrup Andersen, Stig .
JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (05) :532-539
[45]   ICD-10 Codes to Identify Adverse Drug Events Associated with Antibiotics in Administrative Data [J].
Lishman, Hannah ;
Cragg, Amber ;
Chuang, Erica ;
Zou, Carl ;
Marra, Fawziah ;
Grant, Jennifer ;
Patrick, David M. ;
Hohl, Corinne M. .
ANTIBIOTICS-BASEL, 2025, 14 (03)
[46]   Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study [J].
Nomura, Koichi ;
Suda, Satoshi ;
Abe, Arata ;
Iguchi, Yasuyuki ;
Yagita, Yoshiki ;
Kanzawa, Takao ;
Okubo, Seiji ;
Fujimoto, Shigeru ;
Kimura, Kazumi .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 448
[47]   Patient safety, potential adverse drug events, and medical device design: A human factors engineering approach [J].
Lin, L ;
Vicente, KJ ;
Doyle, DJ .
JOURNAL OF BIOMEDICAL INFORMATICS, 2001, 34 (04) :274-284
[48]   Medication Errors and Adverse Drug Events in Kidney Transplant Recipients: Incidence, Risk Factors, and Clinical Outcomes [J].
Taber, David J. ;
Pilch, Nicole A. ;
Bratton, Charles F. ;
McGillicuddy, John W. ;
Chavin, Kenneth D. ;
Baliga, Prabhakar K. .
PHARMACOTHERAPY, 2012, 32 (12) :1053-1060
[49]   Patient risk factors for opioid-related adverse drug events in hospitalized patients: A systematic review [J].
Yiu, Chin Hang ;
Vitharana, Nilru ;
Gnjidic, Danijela ;
Patanwala, Asad E. ;
Fong, Ian ;
Rimington, Joanne ;
Begley, David ;
Bugeja, Bernadette ;
Penm, Jonathan .
PHARMACOTHERAPY, 2022, 42 (03) :194-215
[50]   Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin [J].
Gerotziafas, Grigoris T. ;
Dupont, Charlotte ;
Spyropoulos, Alex C. ;
Hatmi, Mohamed ;
Samama, Meyer M. ;
Kiskinis, Dimitris ;
Elalamy, Ismail .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (01) :42-48